Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemia [RNA-seq]
RNA-seq (gene expression) · human · 70 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 70 samples: 18 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemiaBlood · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE287297_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1212059 and SRA study SRP558126. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 40 samples.
How we read this: 18 replicated groups read from 70 sample titles; they account for 40 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8743247 CHRF-288-11 cell line
- GSM8743248 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (AAVS) batch 1 rep1 at day 34
- GSM8743249 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA1) batch 1 rep1 at day 34
- GSM8743250 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA2) batch 1 rep1 at day 34
- GSM8743251 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA1) batch 1 rep1 at day 34
- GSM8743252 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (AAVS) batch 1 rep2 at day 34
- GSM8743253 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA1) batch 1 rep2 at day 34
- GSM8743254 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA2) batch 1 rep2 at day 34
- GSM8743255 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA1) batch 1 rep2 at day 34
- GSM8743256 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (AAVS) batch 1 rep3 at day 34
- GSM8743257 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA1) batch 1 rep3 at day 34
- GSM8743258 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA2) batch 1 rep3 at day 34
- GSM8743259 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA1) batch 1 rep3 at day 34
- GSM8743260 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (AAVS) batch 2 rep1 at day 39
- GSM8743261 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (AAVS) batch 2 rep2 at day 39
- GSM8743262 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (AAVS) batch 2 rep3 at day 39
- GSM8743263 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA1) batch 2 rep1 at day 39
- GSM8743264 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA1) batch 2 rep2 at day 39
- GSM8743265 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA1) batch 2 rep3 at day 39
- GSM8743266 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA2) batch 2 rep1 at day 39
- GSM8743267 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA2) batch 2 rep2 at day 39
- GSM8743268 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA2) batch 2 rep3 at day 39
- GSM8743269 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA1) batch 2 rep1 at day 39
- GSM8743270 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA1) batch 2 rep2 at day 39
- GSM8743271 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA1) batch 2 rep3 at day 39
- GSM8743272 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA2) batch 2 rep1 at day 39
- GSM8743273 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA2) batch 2 rep2 at day 39
- GSM8743274 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA2) batch 2 rep3 at day 39
- GSM8743275 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (AAVS) + DMSO-treatment (7 days) batch 2 rep1 KDM5A and Cas9 + gRNA (…
- GSM8743276 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA1) + DMSO-treatment (7 days) batch 2 rep1 KDM5A and Cas9 + gRNA (…
- GSM8743277 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA1) + DMSO-treatment (7 days) batch 2 rep1 KDM5A and Cas9 + gRNA (…
- GSM8743278 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (AAVS) + DMSO-treatment (7 days) batch 2 rep2 KDM5A and Cas9 + gRNA (…
- GSM8743279 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA1) + DMSO-treatment (7 days) batch 2 rep2 KDM5A and Cas9 + gRNA (…
- GSM8743280 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA1) + DMSO-treatment (7 days) batch 2 rep2 KDM5A and Cas9 + gRNA (…
- GSM8743281 cord blood CD34+ cell with NUP98::KDM5A + DMSO-treatment (7 days)
- GSM8743282 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA1) + DMSO-treatment (7 days) batch 2 rep3 KDM5A and Cas9 + gRNA (…
- GSM8743283 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA1) + DMSO-treatment (7 days) batch 2 rep3 KDM5A and Cas9 + gRNA (…
- GSM8743284 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (AAVS) + Revumenib (1 uM)-treatment (7 days) batch 2 rep1 KDM5A and Cas9 + gRNA (…
- GSM8743285 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (RB1-gRNA1) + Revumenib (1 uM)-treatment (7 days) batch 2 rep1 KDM5A and Cas9 + gRNA (…
- GSM8743286 cord blood CD34+ cell with NUP98::KDM5A and Cas9 + gRNA (WT1-gRNA1) + Revumenib (1 uM)-treatment (7 days) batch 2 rep1 KDM5A and Cas9 + gRNA (…
+ 30 more — browse all 70 samples with per-sample file links →
- GSE287716 Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemia 13 samples shares nup98-rearranged, oncoproteins, cooperating, phenotypes, mutations, leukemia, fusion
- GSE243183 EWSR1::FLI1 fusion oncoproteins’ regulation of ETS1 (RNA-seq) 18 samples shares oncoproteins, rna-seq, fusion
- GSE276073 Targeting SUMO2 reverses aberrant epigenetic rewiring driven by SS18::SSX fusion oncoproteins and impairs sarcomagenesis [RNA-seq] 12 samples shares oncoproteins, rna-seq, fusion
- GSE234552 Tracking of donor and recipient immune and leukemia phenotypes after allogeneic stem cell transplantation using mitochondrial DNA mutations. [ASAP-Seq 2] 30 samples shares phenotypes, mutations, leukemia
- GSE275725 Tracking of donor and recipient immune and leukemia phenotypes after allogeneic stem cell transplantation using mitochondrial DNA mutations. [ASAP-Seq 4] 22 samples shares phenotypes, mutations, leukemia
- GSE234555 Tracking of donor and recipient immune and leukemia phenotypes after allogeneic stem cell transplantation using mitochondrial DNA mutations. [ASAP-Seq 3] 14 samples shares phenotypes, mutations, leukemia
- GSE234556 Tracking of donor and recipient immune and leukemia phenotypes after allogeneic stem cell transplantation using mitochondrial DNA mutations. [Tapestri] 10 samples shares phenotypes, mutations, leukemia
- GSE234551 Tracking of donor and recipient immune and leukemia phenotypes after allogeneic stem cell transplantation using mitochondrial DNA mutations. [ASAP-Seq 1] 9 samples shares phenotypes, mutations, leukemia
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.